HIV Real Talk: An educational webcast about HIV drug resistance www.HIVREALTALK.com   Ryan White Care Act Hepatitis C & B Language (click here for details)   2008-2009 Request For Treatment Education Proposals, Tibotec Therapeutics STEP Initiative: Strengthening Treatment Education for People Living with HIV/AIDS Therapeutics STEP Initiative   UCSF Anal Cancer Information Website: screening, treatment, and referral list of doctors in numerous cities (click here for details)   Current HIV Articles and News Updates     HIV     AIDS Denialism by South African Govt Leader Pres Mbeki Loses 330,000 Lives & 35,000 HIV+ Babies Born - (01/05/09)   The incidence of and risk factors for MRSA bacteraemia in an HIV-infected cohort in the HAART era - (01/05/09)   Long-term consequences of the delay between virologic failure of HAART and regimen modification - (01/05/09)   Minority Quasispecies of Drug-Resistant HIV-1 That Lead to Early Therapy Failure in Treatment-Naive and -Adherent Patients - (01/05/09)   The Management of Treatment-Experienced HIV-Infected Patients: New Drugs and Drug Combinations - (01/05/09)   More HIV Articles...         News Updates     German govt "to force drugmakers to sell through wholesalers" - (01/05/09)   What Lies Behind the Fall in the HIV Population in India? - (01/05/09)   Pfizer eyes merger deal with large rival - (01/05/09)   More New Updates Articles...     Current Hepatitis C and B Articles     Hepatitis C     Influence of aminotransferase values on liver stiffness measurement: the case of HIV-infected patients with acute viral hepatitis B or C - (01/02/09)   XTL Biopharmaceuticals Signs $108 Million Deal for the Licensing of its Pre-Clinical NS5A Program in Hepatitis C to Presidio Pharmaceuticals - (12/30/08)   More Hep C Articles...         Hepatitis B     Efficacy and Safety of Entecavir in Patients With Chronic Hepatitis B and Advanced Hepatic Fibrosis or Cirrhosis - (01/05/08)   A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2008 Update - (12/23/08)   More Hep B Articles...   Check Out Our Special NATAP Features   The International Symposium on Viral Hepatitis and Liver Disease (ISVHLD)   IAS Conference on HIV Pathogenesis, Treatment and Prevention   International Workshop on Hepatitis C, Resistance and New Compounds   International Workshop on Clinical Pharmacology of Hepatitis Therapy   ICAAC - Interscience Conference On Antimicrobial Agents & Chemotherapy (ICAAC)   International Symposium on Hepatitis C and Related Viruses   Infectious Diseases Society of America (IDSA)   Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)   International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV   European Conference on Clinical Aspects and Treatment of HIV-Infection (EACS)   Association Of Nurses In AIDS Care (ANAC)   International Workshop Targeting HIV Entry   National Viral Hepatitis Prevention Conference   International HIV and Hepatitis Co-infection Workshop   European HIV Drug Resistance Workshop   International Workshop on Clinical Pharmacology of HIV Therapy   International HIV Drug Resistance Workshop   International AIDS Conference   International Workshop on Clinical Pharmacology of HIV Therapy   International Workshop on Clinical Pharmacology of Hepatitis Therapy   Annual Meeting of the European Association for the Study of the Liver (EASL)   Digestive Disease Week   International HIV Drug Resistance Workshop   HIV DART 2008 December 9-12, 2008 Rio Grande, Puerto Rico   Targeting HIV Entry: 4th International Workshop December 8-9, 2008, Rio Grande, Puerto Rico   9th International Congress on Drug Therapy in HIV Infection November 9-13, 2008, Glasgow   10th Intl Workshop on Adverse Drug Reactions and Lipodystrophy in HIV London, UK Nov 6-8 2008   59th Annual Meeting of the American Association for the Study of Liver Diseases Oct 31-Nov 1 2008 San Francisco, CA   48th Annual ICAAC / IDSA 46th Annual Meeting October 25-28, 2008 Washington, DC   3rd International Workshop on HIV Transmission: Principles of Intervention July 31-August 2, 2008 Mexico City   XVII International AIDS Conference 3-8 August 2008 Mexico City   XVII International HIV Drug Resistance Workshop June 10-14, 2008 Sitges, Spain   Digestive Disease Week (DDW) May 17-22, 2008 San Diego, CA   EASL: 43rd Annual Meeting of the European Association For The Study Of The Liver April 23-27, 2008 Milan, Italy   9th International Workshop on Clinical Pharmacology of HIV Therapy and The 3rd International Workshop on Clinical Pharmacology of Hepatitis Therapy 7-9 April 2008 New Orleans   6th European HIV Drug Resistance Workshop Budapest, Hungary March 26-28, 2008   15th CROI Conference on Retroviruses and Opportunistic Infections Boston, MA Feb 3-6, 2008   Targeting HIV Entry: 3rd International Workshop Washington, DC December 7-9, 2007   AASLD American Association For The Study of Liver Diseases Boston, MA November 2-6, 2007   11th European AIDS Conference Madrid October 24-27, 2007   IDSA Conference Infectious Disease Society San Diego, CA, Oct 7, 2007   View More Conference Reports...   New Goals and New Drugs for People With Heavy Anti-HIV Drug Experience - 06/05/07 Do you have HIV/HCV Coinfection? - 11/28/06 HIV 101 : The Basics - 11/28/06 VIH 101 : Lo Basico - in Spanish - 11/28/06 HIV 102 : Care and Treatment of HIV - 11/28/06 VIH 102 : Cuidado Y Tratamiento del VIH - in Spanish - 11/28/06 Hepatitis C and Hepatitis C Co-Infection Handbook PDF Version V 11/08/05 Download More NATAP Publications... Support provided by: Abbott, Bristol-Myers Squibb, Gilead, GlaxoSmithKline, Merck, Roche, Schering-Plough, Tibotec, Vertex   Patient Assistance Programs for HCV Therapy from the Drug Manufacturers: Pegylated Interferon and ribavirin If you cannot get reimbursement or coverage for pegylated interferon and ribavirin the manufacturers of pegylated interferon have reimbursement programs which supply free drugs if you qualify. These programs will first help you try to identify sources for reimbursement.   Schering makes Peg-Intron and ribavirin (Rebetol): Call 1-800-521-7157. Roche makes Pegasys and ribavirin (Copegus): 1-800-387-1258.